"Medicinal Cannabis - Advanced Mental Health" is a comprehensive exploration of the role of medicinal cannabis in addressing mental health disorders. Divided into four units, the course combines evidence-based insights, clinical expertise, and practical tools to enhance patient outcomes.
Unit 1: Introduction to Medicinal Cannabis for Mental Health
This unit lays the foundation for understanding the pharmacological diversity of cannabis. Topics include:
- The distinction between THC-dominant, CBD-dominant, and balanced formulations
- Routes of administration, including vaporisation and oral delivery
- The importance of standardisation and regulation in medicinal cannabis products
- Initial insights into mental health conditions treated with cannabis, such as anxiety and PTSD.
Unit 2: Medicinal Cannabis and Mental Disorders
Focusing on specific mental health conditions, this unit explores:
- The prevalence of cannabis use for anxiety, depression, PTSD, and bipolar disorder
- Reported benefits such as anxiety reduction, improved sleep, and mood stabilisation
- Side effects, including the potential for increased anxiety or depression
- Evidence gaps and the need for placebo-controlled clinical trials
- Key considerations for safe prescribing, especially in populations with psychosis or a history of substance abuse.
Unit 3: Medicinal Cannabis and PTSD
This unit delves into the application of medicinal cannabis in managing PTSD:
- The neurobiological basis of PTSD and its symptoms, including nightmares and emotional numbing
- Evidence from preclinical research suggesting THC and CBD may impair and extinguish traumatic memories
- Studies examining the use of cannabis in military and first-responder populations
- The promise and limitations of synthetic cannabinoids like Nabilone in reducing PTSD symptoms
- The critical need for large-scale, controlled studies to validate early findings.
Unit 4: Potential Benefits and Considerations for Mental Health
This unit highlights the therapeutic promise of CBD for mental health:
- Evidence supporting its anxiolytic and antipsychotic properties
- Studies on its efficacy in reducing anxiety and schizophrenia symptoms without common side effects of traditional medications
- Neuroprotective properties such as anti-inflammatory and antioxidant effects
- Insights into drug interactions between cannabis-based medicines and conventional treatments
- Emerging clinical trials aimed at solidifying the role of CBD in mental health care.
By the end of the course, participants will be equipped with a nuanced understanding of medicinal cannabis, its therapeutic applications, and the clinical considerations necessary to safely and effectively integrate it into mental health treatment plans.
Learning Outcomes
- Manage complex mental health issues with medicinal cannabis including treatment and techniques for schizophrenia, bipolar, severe anxiety and depression.
Details
Cost: Please refer to Healthcert's website
Suitable for: All degree qualified medical practitioners
Study mode: 100% online
Disclaimer: Please note, once you click 'Register now' you will be leaving the AMA’s CPD Home website and entering a third-party education provider’s website. If you choose to register for this learning, you will need to provide some of your personal information directly to the third-party education provider. If you have any queries about how third-party education providers use, disclose or store your personal information you should consult their privacy policy.
Upon completion, your CPD activity record may take up to 4 weeks to be reflected on your CPD Home Dashboard.